Literature DB >> 16270191

Medium-term effects of chemotherapy in older cancer patients.

Barbara Eberhardt1, Stefan Dilger, Frauke Musial, Ulrich Wedding, Thomas Weiss, Wolfgang H R Miltner.   

Abstract

PURPOSE: To address the lack of research in older cancer patients, the present study prospectively evaluated their cognitive functions across the first six months following diagnosis and chemotherapy. PATIENTS AND METHODS: A total of 77 younger (n=43, age < 60) and older (n=34, age > or = 60) cancer patients with hematological disease or cancer of the intestinal tract took part in the study. Medium-term effects of chemotherapy were examined in these cancer patients by means of a battery of cognitive tests during baseline and six months after start of treatment.
RESULTS: In contrast to baseline verbal learning, word fluency and memory capacity improved in all patients six months after start of treatment. A negative effect of age on cognitive functions could not be demonstrated. Additionally, depression was neither associated with medium-term effects of chemotherapy nor was it related to age.
CONCLUSION: The results suggest that chemotherapy has no negative effects on cognitive functions after the first six months following the onset of treatment. It was demonstrated that complete recovery of cognitive functions is independent of the patient's age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270191     DOI: 10.1007/s00520-005-0894-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  25 in total

1.  A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly.

Authors:  S Monfardini; L Balducci
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

2.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Karen Skalla; Marie B Whedon; Sarah Bivens; Tara Mitchell; E Robert Greenberg; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

3.  Depression in medical in-patients.

Authors:  H S Moffic; E S Paykel
Journal:  Br J Psychiatry       Date:  1975-04       Impact factor: 9.319

Review 4.  Psychological aspects of cancer and chemotherapy.

Authors:  A Cull
Journal:  J Psychosom Res       Date:  1990       Impact factor: 3.006

5.  Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

Authors:  S B Schagen; F S van Dam; M J Muller; W Boogerd; J Lindeboom; P F Bruning
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

Review 6.  Depression in the medically ill: an overview.

Authors:  G Rodin; K Voshart
Journal:  Am J Psychiatry       Date:  1986-06       Impact factor: 18.112

7.  'Chemobrain' in breast carcinoma?: a prologue.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard Theriault; Aman U Buzdar; Scott Cruickshank; Christina A Meyers
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

8.  Psychosocial-spiritual correlates of death distress in patients with life-threatening medical conditions.

Authors:  John T Chibnall; Susan D Videen; Paul N Duckro; Douglas K Miller
Journal:  Palliat Med       Date:  2002-07       Impact factor: 4.762

9.  Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population.

Authors:  Adam B Smith; Peter J Selby; Galina Velikova; Dan Stark; E Penny Wright; Ann Gould; Ann Cull
Journal:  Psychol Psychother       Date:  2002-06       Impact factor: 3.915

10.  Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.

Authors:  S B Schagen; M J Muller; W Boogerd; R M Rosenbrand; D van Rhijn; S Rodenhuis; F S A M van Dam
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976

View more
  3 in total

Review 1.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

2.  Short-term monitoring of cognitive functions before and during the first course of treatment.

Authors:  Barbara Eberhardt; Stefan Dilger; Frauke Musial; Ulrich Wedding; Thomas Weiss; Wolfgang H R Miltner
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-14       Impact factor: 4.553

Review 3.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.